Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Ochre Bio is Hiring Flyer

Ochre is looking for a candidate to drive the IP portfolio of this high-growth company in the biotech industry. Reporting directly to our CEO and with specialist IP firms/advisors to support, the IP Director will work in a fast-paced team environment on a broad range of intellectual property matters helping to build and maintain a strong IP portfolio protecting Ochre’s innovation and drug development efforts. This person will work closely with scientists and management, possess good business and legal sense, and have a solid understanding of intellectual property laws and concepts related to the biopharmaceutical business strategies and patents. Ochre is looking for a pragmatic, enthusiastic, business-minded individual with excellent organisational skills and strong attention to detail.

Ochre Bio (www.ochre-bio.com) is a genomics medicines company building on its Deep Phenotyping platform to develop complex RNA therapies to improve the lives of liver transplant, fatty liver (NASH/NAFL) and cardiometabolic disease patients. Ochre is developing novel GalNAc-siRNA therapeutics to reprogram liver metabolism. An overview of our mission and approach can be found here.

Privately held, Ochre is a multinational, dynamic team of computational and experimental biologists, led by seasoned drug developers and biotech professionals. Ochre is funded by top therapeutics and technology investors and advised by world leaders in their respective fields. Ochre Bio is rapidly growing, and you will have the opportunity to drive the development of an impactful patent portfolio, the key to getting life-saving medicines toward the clinic.

Summary of Key Responsibilities:

The IP Director will drive the creation of new patent applications and expand Ochre’s intellectual property portfolio, including:

  • Develop a deep understanding of Ochre’s RNAi technology from both chemical and biological perspectives.
  • Actively prosecute patent portfolio, drafting/filing patent applications directed to RNAi therapeutic agents and any delivery technologies, conducting patentability assessments, reviewing and advising on responses to PTO communications, and participating in examiner interviews.
  • Assist/perform in prior art searches, analysing patents, assist in patentability opinions.
  • Conduct freedom-to-operate searches, infringement, validity assessments, and assist in the preparation of FTO opinions in support of R&D efforts.
  • Liaise and coordinate activities with external legal counsel and foreign patent attorneys.
  • Educate and advise employees and business stakeholders on IP matters.
  • Advise on data protection and other forms of exclusivity.
  • Participate in due diligence with outside counsel to evaluate IP portfolio and strategy regarding business development in support of research collaborations and licensing opportunities.
  • Assist with other general legal matters, as appropriate.

Qualifications:

  • Advanced degree in biology, chemistry or biochemistry (or life sciences) required, PhD preferred.
  • 5+ years of in-house legal setting or law firm experience in the preparation and prosecution of patent applications, preferable with experience in the oligonucleotide therapeutic space.
  • Admitted to practice before the EPO / USPTO, with an excellent understanding of patent prosecution practice, rules, regulations, and filing strategies.
  • Familiarity with scientific and IP databases.
  • Excellent writing, analytical and communication skills.
  • Organized, independent and detailed oriented.

As with all Ochre Bio team members, we expect our Director of Intellectual Property to uphold our three core company values. Excellence in these values is considered as important as scientific excellence:

1. Speed. Sadly, there is no substitute for money to help us scientifically achieve, but a close second is speed. At Ochre Bio, timelines are everything, even if we need to switch to plan B (or plan C).

2. Value-based innovation. Innovation needs to be better, cheaper, or faster than how things are currently done. Investing 20% of our time to achieve a 1% improvement is not likely to be valuable. At Ochre Bio, we use the concept of ‘minimum viable product’ (MVP) as a great way to ensure that we know when to move on.

3. Solutions focused. If there is a hurdle, highlight it. But do so with a solution in hand (or better yet, two solutions in hand). We fully expect failure as a routine part of research but, equally, expect our biotechnologists to bounce back quickly with new ideas.

As a member of the team, our commitment to you is:

1. A competitive salary and equity compensation package.

2. £2,500 for personal IT and WFH equipment, i.e. laptops, desks, etc., renewable after 3 years.

3. 6.5% employer pension contribution on the basis that employees contribute a matching 6.5% pension contribution.

4. The option to join the company’s phone plan, covering monthly work-related phone costs.

5. Personal/professional development support. Within the first few weeks of joining, we ask that you complete a table of personal/professional goals. These might, for example, be scientific/leadership training, CV items you’d like to achieve, or personal strengths you’d like to develop. We will commit to a sponsorship plan to help you achieve these.

To apply, please email contact@ochre-bio.com with your resume and highlighting any relevant experience.